-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KCuOfS5wMqkUyEGmH631csKxwSYY31XyRfw8KQWbs/hLbwi9e3u7fXNJzccWR4dk 2ZdFV/HHzDLgcwYYgADSOw== 0000950120-08-000258.txt : 20080605 0000950120-08-000258.hdr.sgml : 20080605 20080605144832 ACCESSION NUMBER: 0000950120-08-000258 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080603 FILED AS OF DATE: 20080605 DATE AS OF CHANGE: 20080605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: (301) 795-1800 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Biologika, L.L.C. CENTRAL INDEX KEY: 0001380794 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 08882779 BUSINESS ADDRESS: STREET 1: 11308 GLEN RD. CITY: POTOMAC STATE: MD ZIP: 20854 BUSINESS PHONE: 301-983-2295 MAIL ADDRESS: STREET 1: 11308 GLEN RD. CITY: POTOMAC STATE: MD ZIP: 20854 4 1 biol-emerform4_0605ex.xml X0202 4 2008-06-03 0 0001367644 Emergent BioSolutions Inc. EBS 0001380794 Biologika, L.L.C. 11308 GLEN RD. POTOMAC MD 20854 0 0 0 1 Member 13(d) group owning >10% Common Stock 2008-06-03 4 S 0 100 10.00 D 1429664 D Common Stock 2008-06-03 4 S 0 600 10.02 D 1429064 D Common Stock 2008-06-03 4 S 0 100 10.05 D 1428964 D Common Stock 2008-06-03 4 S 0 800 10.06 D 1428164 D Common Stock 2008-06-03 4 S 0 1100 10.07 D 1427064 D Common Stock 2008-06-03 4 S 0 100 10.09 D 1426964 D Common Stock 2008-06-03 4 S 0 100 10.17 D 1426864 D Common Stock 2008-06-03 4 S 0 400 10.18 D 1426464 D Common Stock 2008-06-03 4 S 0 3300 10.19 D 1423164 D Common Stock 2008-06-03 4 S 0 700 10.20 D 1422464 D Common Stock 2008-06-03 4 S 0 2900 10.21 D 1419564 D Common Stock 2008-06-03 4 S 0 700 10.23 D 1418864 D Common Stock 2008-06-03 4 S 0 1000 10.24 D 1417864 D Common Stock 2008-06-03 4 S 0 1500 10.25 D 1416364 D Common Stock 2008-06-03 4 S 0 300 10.27 D 1416064 D Common Stock 2008-06-03 4 S 0 100 10.28 D 1415964 D Common Stock 2008-06-03 4 S 0 100 10.30 D 1415864 D Common Stock 2008-06-03 4 S 0 1300 10.32 D 1414564 D Common Stock 2008-06-03 4 S 0 100 10.33 D 1414464 D Common Stock 2008-06-03 4 S 0 200 10.34 D 1414264 D Common Stock 2008-06-03 4 S 0 100 10.35 D 1414164 D Common Stock 2008-06-03 4 S 0 700 10.37 D 1413464 D Common Stock 2008-06-03 4 S 0 1900 10.38 D 1411564 D Common Stock 2008-06-03 4 S 0 500 10.39 D 1411064 D Common Stock 2008-06-03 4 S 0 900 10.40 D 1410164 D Common Stock 2008-06-03 4 S 0 100 10.42 D 1410064 D Common Stock 2008-06-03 4 S 0 100 10.45 D 1409964 D Common Stock 2008-06-03 4 S 0 200 10.50 D 1409764 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2008. /s/ Carl A. Valenstein, attorney-in-fact 2008-06-05 -----END PRIVACY-ENHANCED MESSAGE-----